Akorn Company Profile (NASDAQ:AKRX)

Analyst Ratings

Consensus Ratings for Akorn (NASDAQ:AKRX) (?)
Ratings Breakdown: 4 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Buy (Score: 2.69)
Consensus Price Target: $34.58 (1.02% upside)

Analysts' Ratings History for Akorn (NASDAQ:AKRX)
Show:
DateFirmActionRatingPrice TargetActions
7/28/2016RBC Capital MarketsReiterated RatingOutperform$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/18/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Leerink SwannReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/17/2016GuggenheimReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016Jefferies GroupReiterated RatingBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/22/2016Craig HallumReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016Piper Jaffray Cos.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016SusquehannaLower Price TargetNeutral$32.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016William BlairReiterated RatingOutperform$58.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/22/2016S&P Equity ResearchLower Price Target$25.98 -> $21.97View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016Raymond James Financial Inc.Lower Price Target$53.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016NomuraLower Price TargetBuy$46.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2016Deutsche Bank AGLower Price TargetBuy$40.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016JPMorgan Chase & Co.Lower Price TargetOverweight$50.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Avondale PartnersInitiated CoverageOutperform$56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015WallachBeth CapitalBoost Price TargetBuy$43.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2015Sterne Agee CRTInitiated CoverageBuy$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2014CRT CapitalUpgradeFair Value -> Buy$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Akorn (NASDAQ:AKRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016ListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/16/2016Q116$0.43$0.54$268.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414$0.45$0.50$218.87 million$227.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314$0.25$0.27$155.20 million$132.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$0.20$0.25$145.16 million$150.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114$0.15$0.16$91.44 million$90.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2014Q413$0.14$0.14$83.37 million$85.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313$0.14$0.15$80.43 million$81.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013$0.13$0.14$75.06 million$77.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013$0.14$0.13$74.07 million$73.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2013Q4 2012$0.12$0.13$69.42 million$71.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2012Q312$0.13$0.12$69.59 million$69.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012$0.12$0.12ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2012$0.12$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2012$0.09$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$0.06$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Akorn (NASDAQ:AKRX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.50$0.50$0.50
Q2 20162$0.47$0.53$0.50
Q3 20161$0.53$0.53$0.53
Q4 20161$0.52$0.52$0.52
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Akorn (NASDAQ:AKRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Akorn (NASDAQ:AKRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/14/2016Joseph BonaccorsiSVPSell6,500$29.84$193,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2016Kenneth AbramowitzDirectorSell14,675$30.16$442,598.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Bruce KutinskyCOOSell142,000$31.12$4,419,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Ronald M JohnsonDirectorSell7,542$31.49$237,497.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016Kenneth AbramowitzDirectorSell10,900$31.37$341,933.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Joseph BonaccorsiSVPSell90,250$31.23$2,818,507.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2016Alan D WeinsteinDirectorSell50,000$30.93$1,546,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2015Mark M SilverbergVPSell29,000$55.00$1,595,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015John N KapoorDirectorBuy19,000$44.26$840,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Rajat RaiCEOBuy5,000$47.70$238,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Joseph BonaccorsiInsiderSell40,827$47.33$1,932,341.91View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Ronald M JohnsonDirectorSell17,173$46.44$797,514.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2015Rajat RaiCEOSell873,985$41.89$36,611,231.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Mark M SilverbergVPSell38,602$41.00$1,582,682.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Ronald M JohnsonDirectorSell17,173$40.46$694,819.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Ronald M JohnsonDirectorSell14,300$36.12$516,516.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Timothy A DickCFOSell30,150$36.03$1,086,304.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Brian TambiDirectorSell1,200$41.86$50,232.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Adrienne L GravesDirectorSell9,557$41.09$392,697.13View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2014John N KapoorDirectorSell50,000$41.19$2,059,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014John R SabatVPSell43,173$40.53$1,749,801.69View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Timothy A DickCFOSell30,875$39.23$1,211,226.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Timothy A DickCFOSell122,222$44.08$5,387,545.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Timothy A DickCFOSell122,222$35.24$4,307,103.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2014Brian TambiDirectorSell13,800$38.00$524,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2014Joseph BonaccorsiInsiderSell116,800$37.89$4,425,552.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Kenneth AbramowitzDirectorSell4,500$36.54$164,430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Rajat RaiCEOSell147,000$36.78$5,406,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Timothy A DickCFOSell45,000$37.61$1,692,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014Alan D WeinsteinDirectorSell5,000$38.49$192,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014John N KapoorDirectorSell50,000$38.99$1,949,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Rajat RaiCEOSell903,659$33.62$30,381,015.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2014Brian TambiDirectorBuy1,000$27.62$27,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2014Rajat RaiCEOBuy5,000$26.76$133,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Kenneth AbramowitzDirectorSell2,557$26.79$68,502.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013Alan WeinsteinDirectorSell20,000$25.52$510,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2013Kenneth AbramowitzDirectorSell5,000$25.35$126,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2012Alan D WeinsteinDirectorBuy30,500$13.67$416,935.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Akorn (NASDAQ:AKRX)
DateHeadline
07/26/16 02:26 PMAnalysts Ranking Previews: Mast Therapeutics, Inc. (NYSEMKT:MSTX) , Akorn, Inc. (NASDAQ:AKRX) - Street Updates
07/23/16 02:24 PMStocks Alert: Mack-Cali Realty Corp. (CLI), Akorn, Inc. (AKRX), Plug Power Inc. (PLUG) - iStreetWire
07/23/16 02:24 PMStock Up Nicely This Week: Akorn, Inc. (NASDAQ:AKRX) - TGP
07/23/16 02:24 PMStock Performance Rundown on Akorn, Inc. (NASDAQ:AKRX) - Engelwood Daily
07/23/16 06:52 AMTwin Securities INC Increased Akorn INC (NASDAQ:AKRX) by $48.70 Million as Shares Declined - Press Telegraph
07/22/16 07:25 PMFriday Session Wrap-up for Akorn, Inc. (NASDAQ:AKRX) - Engelwood Daily
07/22/16 02:24 PMEarnings Focus and Crowd Sourced Sentiment Review for Akorn, Inc. (NASDAQ:AKRX) - TGP
07/22/16 02:24 PMAttention Grasping Stock With Upward Momentum: Akorn, Inc. (NASDAQ:AKRX) - TGP
07/21/16 02:24 PMMarket Minute - Focus on Akorn, Inc. (NASDAQ:AKRX) Stock - TGP
07/21/16 02:24 PMHigh Expectations Remain For Akorn, Inc. (NASDAQ:AKRX) - TGP
07/21/16 07:05 AMAkorn Announces Second Quarter 2016 Earnings Release and Conference Call Information - [GlobeNewswire] - LAKE FOREST, Ill., July 21, 2016-- Akorn, Inc., a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on Thursday, August 4, 2016 outlining the second ...
07/20/16 09:51 PMShares Positive Over the Past Month: Akorn, Inc. (NASDAQ:AKRX) - TGP
07/20/16 09:51 PMStock Strength in Focus for Akorn, Inc. (NASDAQ:AKRX) - Press Telegraph
07/19/16 02:25 PMEquity Roundup: Stock Performance Focus on Akorn, Inc. (NASDAQ:AKRX) - Press Telegraph
07/19/16 02:25 PMLong Term Value Play: Akorn, Inc. (NASDAQ:AKRX) - TGP
07/19/16 08:37 AMShares Lower on the Year Akorn, Inc. (NASDAQ:AKRX) - Press Telegraph
07/18/16 02:27 PMAkorn, Inc. (NASDAQ:AKRX): Trading Session Stock Performance Report - Press Telegraph
07/17/16 07:10 AMReview on Stock Valuation for: Akorn, Inc. (NASDAQ:AKRX) - TGP
07/17/16 07:10 AMTwin Securities INC Increased Akorn INC (NASDAQ:AKRX) by $48.70 Million as Shares Declined - Consumer Eagle
07/17/16 07:10 AMShare Performance Summary for: Akorn, Inc. (NASDAQ:AKRX) - Press Telegraph
07/15/16 01:00 PMConsensus Target and Stock Rating Report: Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/15/16 01:00 PMDon't Miss This Chance To Buy Akorn Inc (NASDAQ:AKRX) - Street Report
07/14/16 07:53 PMAkorn, Inc. (NASDAQ:AKRX): Stock Review and Performance Update - Press Telegraph
07/14/16 07:53 PMAkorn, Inc. (NASDAQ:AKRX) Analyst Average Stock Rating - Engelwood Daily
07/14/16 07:53 PMSachem Head Capital Management LP Decreased Stake in Akorn INC (NASDAQ:AKRX) by $19.32 Million as Shares ... - Consumer Eagle
07/14/16 02:26 PMAnalysts are Watching Shares of: Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/13/16 02:25 PMShares Turning Downward: Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/13/16 02:25 PMAnalysts Ranking Previews: Aetna Inc. (NYSE:AET) , Akorn, Inc. (NASDAQ:AKRX) - Street Updates
07/12/16 02:28 PMAnalyst Ratings and Target Price Check on : Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/12/16 02:28 PMHow Analysts Feel About Akorn, Inc. (NASDAQ:AKRX)? - Consumer Eagle
07/12/16 07:32 AMAkorn, Inc. (NASDAQ:AKRX) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/12/16 07:32 AMStock for the Ages: Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/12/16 07:32 AMTrading Performance and Target Watch for Akorn, Inc. (NASDAQ:AKRX) - Press Telegraph
07/12/16 07:32 AMShares Moving Up Over the Past Quarter: Akorn, Inc. (NASDAQ:AKRX) - Engelwood Daily
07/12/16 07:32 AMStock Down on the Year Akorn, Inc. (NASDAQ:AKRX) - Press Telegraph
07/11/16 07:12 AMStock Performance Rundown on: Akorn, Inc. (NASDAQ:AKRX) - Press Telegraph
07/10/16 02:23 PMShare Valuation Recap for: Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/10/16 02:23 PMAkorn, Inc. (NASDAQ:AKRX): Check on Company Stock Performance - Press Telegraph
07/08/16 07:36 PMAkorn, Inc. (NASDAQ:AKRX): Tracking Consensus Projections and Analyst Ratings - Telanagana Press
07/08/16 07:36 PMSession Update - Stock in Motion: Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/08/16 02:25 PMWall Street Ratings and Target Price Views on Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/08/16 02:25 PMFast Growth for Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/08/16 02:25 PMSachem Head Capital Management LP Decreased Stake in Akorn INC (NASDAQ:AKRX) by $19.32 Million as Shares ... - Press Telegraph
07/07/16 02:25 PMAkorn, Inc. (NASDAQ:AKRX) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/07/16 02:25 PMShares Declining and Worrying Investors: Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/07/16 02:25 PMInsiders are Gradually Selling Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/07/16 02:25 PMShort Information Review for: Akorn, Inc. (NASDAQ:AKRX) - Engelwood Daily
07/06/16 02:25 PMLong Term Growth Stock: Akorn, Inc. (NASDAQ:AKRX) - Telanagana Press
07/06/16 02:25 PMAkorn, Inc. (NASDAQ:AKRX) Current Analyst Ratings - Fiscal Standard
07/06/16 07:13 AMStock Tracking Down This Month; Investor Alert on Akorn, Inc. (NASDAQ:AKRX) - Engelwood Daily

Social

About Akorn

Akorn logoAkorn Inc. (Akorn), together with its wholly owned subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as animal and over-the-counter (OTC) consumer health products. The Company specializes in sterile and non-sterile dosage forms, including ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays. The Company operates in two segments: Prescription Pharmaceuticals, which is engaged in the sale of branded and generic prescription pharmaceuticals, and Consumer Health, which is engaged in the sale of branded and private label consumer and animal health products. The Company operates pharmaceutical manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York, and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: AKRX
  • CUSIP: 00972810
Key Metrics:
  • Previous Close: $34.23
  • 50 Day Moving Average: $30.39
  • 200 Day Moving Average: $27.23
  • P/E Ratio: 27.27
  • P/E Growth: 1.75
  • Market Cap: $4.09B
  • Beta: 0.81
  • Current Year EPS Consensus Estimate: $2.06 EPS
  • Next Year EPS Consensus Estimate: $2.2 EPS
Additional Links:
Akorn (NASDAQ:AKRX) Chart for Saturday, July, 30, 2016